Similarly, Langella et al. (2023) showed that cognitive decline in AD-EOAD is accelerated in APOEε4 carriers and attenuated in APOEε2 carriers, underscoring the allele-specific influence of APOE on disease expression, even in the presence of fully penetrant monogenic mutations [56]. This evidence concerns the gene APOE and Alzheimer disease.